We are excited to introduce retatrutide, a revolutionary medication that offers new possibilities for individuals struggling with their weight
It can cause similar symptoms to a true allergy
These approaches not only extend half-life, but also flatten peaktrough exposure profiles, reducing dose-dependent adverse effects that previously limited development
Based on the April 15, 2026, federal notice and subsequent reporting, GHK-Cu is not scheduled for the July 23-24, 2026, PCAC review
Discard if you notice any visible particles or if the liquid is discoloured
These were generally mild and not classified as serious adverse events, but they establish that retatrutide does have a measurable effect on cardiac rhythm beyond simple rate increase